Dr. Huh has served as Vice President and Head of Clinical Development since September 2022. Dr. Huh is a board-certified pediatric gastroenterologist experienced leader in clinical development, clinical and epidemiologic research, and quality improvement. Before joining Ironwood, Dr. Huh was Senior Medical Director and Global Clinical Lead in the gastrointestinal therapeutic area unit at Takeda Pharmaceuticals, where she led global clinical development for the TAU’s microbiome portfolio, overseeing the clinical strategy for inflammatory bowel disease and liver disease assets in preclinical through Phase 2. Prior to this role, Dr. Huh held clinical development leadership roles in asset programs across phases 1-4 targeting motility, inflammatory bowel disease, and rare pediatric disease.

Dr. Huh is an accomplished clinician and researcher who is Assistant Professor of Pediatrics at Harvard Medical School and a Pediatric Gastroenterologist at Boston Children’s Hospital. Prior to joining Takeda Pharmaceuticals, Dr. Huh’s clinical and research interests focused on the effects of early childhood nutrition on lifelong health. For ten years, Dr. Huh directed the Growth and Nutrition Program, a multidisciplinary program offering diagnosis and treatment for children with malnutrition and feeding difficulties, and she continues a part-time clinical practice in this program. She has held NIH and other research grants, and her research on prenatal and early childhood factors associated with child obesity have earned national media attention.

Dr. Huh has over 20 published research articles and has served as an ad hoc reviewer for multiple journals, including New England Journal of Medicine and The Journal of the American Medical Association (JAMA). She has been a speaker at multiple national and international meetings. She has received mentoring awards, including the Women in the Enterprise of Science and Technology and the David S. Weiner award for leadership and innovation in child health from Boston Children’s Hospital. Dr. Huh earned her M.D. from Western University (Ontario, Canada) and MPH from Harvard T.H. Chan School of Public Health, concentrating on clinical effectiveness. Dr. Huh completed her residency at the Children’s Hospital of Western Ontario and did her fellowship in pediatric gastroenterology and nutrition at Boston Children’s Hospital and Harvard Medical School. She is a member of the advisory boards for Women in the Enterprise of Science and Technology (WEST) and Mother’s Milk Bank Northeast.

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here